Page last updated: 2024-10-17

aminocaproic acid and Osteoarthritis

aminocaproic acid has been researched along with Osteoarthritis in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Osteoarthritis: A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guilarte López-Mañas, J1
Valenzuela Barranco, M1
Caballero Plasencia, AM1
Martín Ruiz, JL1

Trials

1 trial available for aminocaproic acid and Osteoarthritis

ArticleYear
[Endoscopic, histologic and morphometric evaluation of the gastric mucosa in patients with osteoarthritis treated with piroxicam and zinc acexamate].
    Gastroenterologia y hepatologia, 1998, Volume: 21, Issue:5

    Topics: Adult; Aged; Aminocaproates; Aminocaproic Acid; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer

1998